Showing results (1481-1490 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|June 25, 2014
Role of appetite-regulating peptides in the pathophysiology of addiction: implications for pharmacotherapyJörgen A Engel, Elisabet JerlhagCNS Drugs|January 10, 2014
Attention-deficit/hyperactivity disorder with inadequate response to stimulants: approaches to managementAnn C Childress, Floyd R SalleeCNS Drugs|February 7, 2015
Weight regain after discontinuation of topiramate treatment in patients with migraine: a prospective observational studyAlberto Verrotti, Pasquale Parisi, Sergio Agostinelli, et al.CNS Drugs|June 29, 2014
Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizuresGillian M KeatingCNS Drugs|June 20, 2014
Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?Shaun Yon-Seng Khoo, Robyn Mary BrownCNS Drugs|March 1, 2015
Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: current knowledge and clinical implicationsJohann Steiner, Kolja Schiltz, Hans-Gert Bernstein, et al.CNS Drugs|March 17, 2015
Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugsMaria Pia Amato, Emilio PortaccioCNS Drugs|July 2, 2020
Enhancing the Activity of Glucocerebrosidase as a Treatment for Parkinson DiseaseElisa Menozzi, Anthony H V SchapiraCNS Drugs|June 27, 2020
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled TrialYves Dauvilliers, Colin Shapiro, Geert Mayer, et al.CNS Drugs|February 21, 2015
The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of clinical researchNicola C Savill, Jan K Buitelaar, Ernie Anand, et al.Pageof 211